EUVIMEDEUVIMED entdecken
Kohortenstudie

Plasma Metabolite Profiles Linked to EAT‐Lancet Diet and Risk of Inflammatory Bowel Disease: A Prospective Cohort Study From UK Biobank

Xiaohua Ye iD, Chunmin Lou, Zhe Shen

Molecular Nutrition & Food Research · 2025-06 · 69 (11)

DOI: 10.1002/mnfr.70059 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 13.04.2025. Verfasst von Xiaohua Ye und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Diet, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key R&D Program of China, Zhejiang High-Level Talent Innovation Leadership Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The EAT‐Lancet Commission recommends a sustainable, health‐focused diet, but its impact on inflammatory bowel disease (IBD) and metabolic mechanisms remains unclear. This study explores the association between the EAT‐Lancet diet and IBD risk. We included 187 558 participants from the UK Biobank, free from IBD at baseline. Dietary intake was assessed using a validated 24‐h dietary recall, and an EAT‐Lancet diet score was calculated. Incident IBD cases were identified through primary care, hospital data, and death registries. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Over a mean follow‐up of 13.15 years, 571 cases of Crohn's disease (CD) and 1066 of ulcerative colitis (UC) were recorded. HRs per 1‐point increase in the EAT‐Lancet score were 0.95 (95% CI: 0.91–0.98) for IBD, 0.95 (95% CI: 0.91–1.00) for UC, and 0.93 (95% CI: 0.87–0.98) for CD. Seven metabolites were identified as mediators, accounting for 10.7% of the association. Greater adherence to the EAT‐Lancet diet was associated with a trend toward reduced IBD risk, with identified metabolites mediating this association. These findings emphasize the nutritional relevance of the EAT‐Lancet diet in reducing IBD risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DietInflammatory Bowel DiseasesHumansFemaleMaleUnited KingdomProspective StudiesMiddle AgedAdultBiological Specimen BanksColitis, UlcerativeRisk FactorsCrohn DiseaseProportional Hazards ModelsAgedUK Biobank

Stichwörter der Autor:innen

EAT‐Lancet dietIBDUK Biobank cohort studydietary patternmetabolites

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
  • Department of Gastroenterology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.

ORCID-Profile: Xiaohua Ye

Förderung

  • National Key R&D Program of China
  • Zhejiang High-Level Talent Innovation Leadership Project

Zitieren

APA

Ye, X., Lou, C., & Shen, Z. (2025). Plasma Metabolite Profiles Linked to EAT‐Lancet Diet and Risk of Inflammatory Bowel Disease: A Prospective Cohort Study From UK Biobank. Molecular Nutrition & Food Research, 69(11). https://doi.org/10.1002/mnfr.70059

Vancouver

Ye X, Lou C, Shen Z. Plasma Metabolite Profiles Linked to EAT‐Lancet Diet and Risk of Inflammatory Bowel Disease: A Prospective Cohort Study From UK Biobank. Molecular Nutrition & Food Research. 2025;69(11). doi:10.1002/mnfr.70059

BibTeX
@article{Ye2025,
  author = {Ye, Xiaohua and Lou, Chunmin and Shen, Zhe},
  title = {Plasma Metabolite Profiles Linked to EAT‐Lancet Diet and Risk of Inflammatory Bowel Disease: A Prospective Cohort Study From UK Biobank},
  journal = {Molecular Nutrition & Food Research},
  year = {2025},
  volume = {69},
  number = {11},
  doi = {10.1002/mnfr.70059}
}
Kostenlos starten →